Global Zika Virus Industry 2016 Market Research Report Trend and Forecast 2021

 Table of Content


1 Industry Overview of Zika Virus 1
1.1 Definition and Specifications of Zika Virus 1
1.1.1 Definition and Specifications of Zika Virus 1
1.1.2 Signs and Symptoms 3
1.1.3 Complications of Zika Virus Disease 3
1.1.4 Diagnosis Zika Virus 3
1.1.5 Treatment Zika Virus 5
1.1.6 WHO Response to Zika Virus 5
2 Transmission of Zika Virus 7
2.1 Mosquito Bites 8
2.1.1 Life Stages of Aedes Aegypti and Aedes Albopictus Mosquitoes 10
2.1.2 Aedes Aegypti 13
2.1.3 Aedes Albopictus 15
2.2 Pregnancy 17
2.3 Sexual Transmission 17
2.4 Blood Transfusion 18
2.4.1 Zika Virus Blood Screening 19
2.4.2 Blood Collection Centers and Health Departments 19
3 Zika Virus, Microcephaly and Guillain-Barre Syndrome 20
3.1 Zika Virus, Microcephaly and Guillain-Barre Syndrome 20
3.2 Microcephaly 21
3.2.1 Signs and Symptoms 22
3.2.2 Causes of Microcephaly 22
3.2.3 Diagnosis and Treatment 22
3.3 Guillain-Barre Syndrome 23
3.3.1 Signs and Symptoms 25
3.3.2 Causes of Guillain-Barre 26
3.3.3 Diagnosis 26
3.4 Dengue and Climate 26
4 Development of Zika Virus 29
4.1 History of Zika Virus 29
4.1.1 1947-1964 29
4.2.2 1960s-1980s 31
4.2.3 2007-2014 31
4.2.4 Situation in 2015 33
4.2.5 Situation in 2016 34
4.2.6 Zika: the origin and spread of a mosquito-borne virus conclusion 36
4.2 Timeline of Zika Virus 37
4.3 Distribution of Zika Virus 39
4.3.1 Distribution of Zika Virus 39
4.3.2 Predicted Habitats of Mosquito Transmits Zika Virus 41
5 Zika Virus Situation by Countries 42
5.1 Current Zika Transmission Situation by Countries 42
5.2 Current Zika Transmission Situation by Regions 45
5.3 Countries and Territories Reporting Mosquito-borne Zika Virus Transmission 45
5.4 Response Funding of Zika Virus 47
6 Operational Response Analysis of Zika Virus 50
6.1 Surveillance of Zika Virus 50
6.1.1 Enhanced Surveillance and Monitoring 50
6.1.2 Laboratories and diagnostics 50
6.1.3 Rapid response 51
6.2 Community Engagement & Risk Communication of Zika Virus 53
6.2.1 Public Health Risk Communication 53
6.2.2 Health Care Personnel 53
6.3 Care for Those Affected of Zika Virus 55
6.3.1 Clinical Guidance and Protocols 55
6.3.2 Preparation of Healthcare Facilities 56
6.3.3 Pre-pregnancy, Maternal and Post-natal Care 56
7 Main Countries Response Analysis of Zika Virus 59
7.1 Brazil Response Analysis of Zika Virus 59
7.1.1 Brazil Zika Virus 59
7.1.2 Brazil Response of Zika Virus 60
7.2 USA Response Analysis of Zika Virus 61
7.2.1 USA Zika Virus 61
7.2.2 USA Response of Zika Virus 61
7.3 Other Countries of Response Analysis of Zika Virus 62
8 Research Situation of Major Companies Analysis of Zika Virus 64
8.1 Bharat Biotech 64
8.1.1 Company Profile 64
8.1.2 Research Status 65
8.2 Inovio Pharmaceuticals and GeneOne Life Sciences 66
8.2.1 Inovio Pharmaceuticals Company Profile 66
8.2.2 GeneOne Life Sciences Company Profile 67
8.2.3 Research Status 68
8.3 Intrexon 70
8.3.1 Company Profile 70
8.3.2 Research Status 71
8.4 Cerus 73
8.4.1 Company Profile 73
8.4.2 Research Status 74
8.5 Sanofi 76
8.5.1 Company Profile 76
8.5.2 Research Status of Sanofi 77
8.6 NewLink Genetics 78
8.6.1 Company Profile 78
8.6.2 Research Status 79
8.7 Immunovaccine 80
8.7.1 Company Profile 80
8.7.2 Research Status 81
8.8 GlaxoSmithKline 83
8.8.1 Company Profile 83
8.8.2 Research Status 84
9 Major Manufacturers Analysis of Zika Virus 87
9.1 ATCC 87
9.1.1 Company Profile 87
9.1.2 Zika Virus (ATCC? VR-84?) 89
9.2 ZeptoMetrix 90
9.2.1 Zika Virus (ATCC? VR-1838?) 90
9.2.2 Company Profile 91
9.2.3 Product Picture and Specifications 92
10 Other Similar Infectious Diseases and Forecast of Zika Virus 93
10.1 Overview of Yellow Fever 93
10.1.1 Definitions and Features of Yellow Fever 93
10.1.2 Distribution of Yellow Fever 94
10.1.3 Transmission of Yellow Fever 95
10.1.4 Yellow Fever Vaccine 95
10.2 Forecast of Zika Virus 97
11 Conclusion of the Global Zika Virus Market 2016 Industry Trend and Forecast 2021 99

List of Tables and Figures


Figure Picture of Zika Virus a Cross-section 2
Figure Picture Parts of Zika Virus 2
Table Signs and Symptoms of Zika Virus 3
Table Diagnosis of Zika Virus 4
Table Treatment Zika Virus 5
Table WHO Response to Zika Virus 5
Table Transmission of Zika Virus 7
Figure Spreads of Zika Virus 7
Figure United States Estimated Range of Aedes Albopictus and Aedes Aegypti in 2016 8
Figure Europe Range of Aedes Albopictus and Aedes Aegypti in 2016 8
Table Compared of Aedes Aegypti and Aedes Albopictus 9
Figure Mosquito Life Cycle 10
Figure Mosquito Life Cycle in Laboratory 11
Table Specifications of Aedes Aegypti 11
Figure Picture of Aedes Aegypti 13
Table Specifications of Aedes Aegypti 13
Table Entomology of Aedes Aegypti 14
Figure Picture of Aedes Albopictus 15
Table Specifications of Aedes Albopictus 15
Table Distribution of Aedes Albopictus 16
Table Entomology of Aedes Albopictus 16
Table Summary of Zika Virus, Microcephaly and Guillain-Barre Syndrome 20
Table Key Facts of Microcephaly 21
Table Key Facts of Guillain-Barre 23
Figure Spectrum of Disorders in the Guillain-Barre Syndrome and Associated Antiganglioside Antibodies 24
Figure Possible Immunopathogenesis of the Guillain-Barre Syndrome 25
Figure Picture of Dengue 27
Figure Picture of Sentinel Rhesus Monkey 30
Table Situation in 2015 of Aedes Aegypti 33
Table Situation in 2016 of Aedes Aegypti 34
Figure 1947-2014 Timeline of Zika Virus 37
Figure 2015 Timeline of Zika Virus 37
Figure 2016 Timeline of Zika Virus 38
Figure Countries, Territories and Areas Distribution of Zika Virus until May 2016 39
Figure Countries and Territories with Active Zika Virus Transmission until May 2016 40
Figure Predicted Habitats of Mosquito Transmits the Zika Virus 41
Figure Predicted Habitats of a Second Mosquito Transmits the Zika Virus 41
Table Current Zika Transmission Situation by Countries 42
Figure Current Zika Transmission Wroldwide 44
Figure Zika Virus Cumulative Number of Countries, Territories and Areas by Regions in Years, 2007-2014, and Monthly from 1 January 2015 to 8 June 2016 45
Table Countries and Territories Reporting Mosquito-borne Zika Virus Transmission 45
Table Countries and Territories Reporting Countries Non Vector-borne Zika Virus Transmission 47
Figure Zika Response Founding Gap for WHO/PAHO 48
Figure Contributions for Zika Emergency Response 49
Figure Key Activities by Authoritative Organizations 51
Figure Key Activities by Authoritative Organizations 54
Table Key Activities by Authoritative Organizations 56
Figure Distribution of Brazil Zika Virus 59
Figure Distribution of USA Zika Virus 61
Table USA Response of Zika Virus 61
Table Bharat Biotech Information List 64
Table Inovio Pharmaceuticals Information List 66
Table GeneOne Life Sciences Information List 67
Figure Research Status of Inovio Pharmaceuticals 68
Table Intrexon Information List 70
Figure Research Status of Intrexon 71
Table Cerus Information List 73
Figure Research Status of Cerus 74
Table Sanofi Information List 76
Figure Research Status of Sanofi 77
Table NewLink Genetics Information List 78
Table Immunovaccine Information List 80
Figure Research Status of Immunovaccine 81
Table GlaxoSmithKline Information List 83
Figure Research Status of GlaxoSmithKline 84
Table ATCC Information List 87
Table Specifications of Zika Virus (ATCC? VR-84?) 89
Table Specifications of (ATCC? VR-1838?) 90
Table ZeptoMetrix Information List 91
Table Product Specifications 92
Figure Distribution of Yellow Fever 94
Figure Price of Yellow Fever Vaccine 96
Figure Yellow Fever Vaccine Manufacturers with WHO Prequalified YFV 96
Table UNICEF YFV 2015 Supply and 2016-2017 Awards 97 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy